4.5 Article

Familial Alzheimer's Disease Osaka Mutant (ΔE22) β-Barrels Suggest an Explanation for the Different Aβ1-40/42 Preferred Conformational States Observed by Experiment

期刊

JOURNAL OF PHYSICAL CHEMISTRY B
卷 117, 期 39, 页码 11518-11529

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jp405389n

关键词

-

资金

  1. Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]
  2. Intramural Research Program of NIH, Frederick National Lab, Center for Cancer Research
  3. National Institutes of Health (National Institute on Aging) [AG028709]

向作者/读者索取更多资源

An unusual Delta E693 mutation in the amyloid precursor protein (APP) producing a beta-amyloid (A beta) peptide lacking glutamic acid at position 22 (Glu22) was recently discovered, and dabbed the Osaka mutant (Delta E22). Previously, several point mutations in the A beta peptide involving Glu22 substitutions were identified and implicated in the early onset of familial Alzheimer's disease (FAD). Despite the absence of Glu22, the Osaka mutant is also associated with FAD, showing a recessive inheritance in families affected by the disease. To see whether this aggregation-prone A beta mutant could directly relate to the A beta ion channel-mediated mechanism as observed for the wild type (WT) Ail peptide in A beta pathology, we modeled Osaka mutant beta-barrels in a lipid bilayer. Using molecular dynamics (MD) simulations, two conformer Delta E22 barrels with the U-shaped monomer conformation derived from NMR-based WT A beta fibrils were simulated in explicit lipid environment. Here, we show that the Delta E22 barrels obtain the lipid-relaxed beta-sheet channel topology, indistinguishable from the WT A beta(1-42) barrels, as do the outer and pore dimensions of octadecameric (18-mer) Delta E22 barrels. Although the Delta E22 barrels lose the cationic binding site in the pore which is normally provided by the negatively charged Glu22 side chains, the mutant pores gain a new cationic binding site by Glu11 at the lower bilayer leaflet, and exhibit ion fluctuations similar to the WT barrels. Of particular interest, this deletion mutant suggests that toxic WT A beta(1-42) would preferentially adopt a less C-terminal turn similar to that observed for A beta(17-42), and explains why the solid state NMR data for A beta(1-40) point to a more C-terminal turn conformation. The observed Delta E22 barrels conformational preferences also suggest an explanation for the lower neurotoxicity in rat primary neurons as compared to WT A beta(1-42).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Allostery, and how to define and measure signal transduction

Ruth Nussinov, Chung-Jung Tsai, Hyunbum Jang

Summary: This article discusses the concept of productive signaling, including its definition, measurement, and determining factors. It highlights the importance of understanding signal propagation in diseases like cancer and neurodevelopmental disorders. The authors propose a framework for investigating signal transduction by defining cellular processes, conducting experimental measurements, and utilizing computational AI algorithms.

BIOPHYSICAL CHEMISTRY (2022)

Article Biophysics

The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia

Yonglan Liu, Hyunbum Jang, Mingzhen Zhang, Chung-Jung Tsai, Ryan Maloney, Ruth Nussinov

Summary: This study provides insights into the molecular mechanism of BCR-ABL recruitment of GRB2, revealing the determinants of specificity in the recognition between SH2(GRB2) and phosphorylated BCR. The findings contribute to the prediction of BCR-binding scaffolds and the design of therapeutic peptides.

BIOPHYSICAL JOURNAL (2022)

Article Biochemistry & Molecular Biology

The mechanism of activation of MEK1 by B-Raf and KSR1

Ryan C. Maloney, Mingzhen Zhang, Yonglan Liu, Hyunbum Jang, Ruth Nussinov

Summary: Interactions between MEK1, B-Raf, and KSR1 are crucial for Ras/Raf/MEK/ERK signaling. Molecular dynamics simulations reveal that the proline-rich loop of MEK1 is essential for the phosphorylation of MEK1 activation loop. In the inactive B-Raf/MEK1 complex, the collapsed A-loop of B-Raf interacts with the P-rich loop and A-loop of MEK1, preventing phosphorylation. In the active B-Raf/MEK1 complex, the P-rich loop moves with the extended A-loop of B-Raf, leading to increased A-loop fluctuation and phosphorylation. KSR1/MEK1 complex has fewer interactions between KSR1 alpha G-helix and MEK1 A-loop, resulting in a more flexible A-loop.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Biochemistry & Molecular Biology

Artificial intelligence approaches to human-microbiome protein-protein interactions

Hansaim Lim, Fatma Cankara, Chung -Jung Tsai, Ozlem Keskin, Ruth Nussinov, Attila Gursoy

Summary: This review discusses recent advancements in computational methods for predicting microbial effects on human cells, with a focus on protein-protein interactions. Traditional methods, as well as more recent deep learning methods, are categorized and potential solutions to challenges in structure-based approaches are discussed. The review provides a brief guide to the current status and future directions in the field.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2022)

Review Biochemistry & Molecular Biology

Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs

Ruth Nussinov, Mingzhen Zhang, Ryan Maloney, Yonglan Liu, Chung -Jung Tsai, Hyunbum Jang

Summary: This article discusses the principles and applications of allosteric activating mutations and drugs, using examples from the Ras signaling network. Specifically, it focuses on Abl kinase mutations that shift the conformation towards an active state, leading to competition between high affinity ATP and drug binding. Recent pharmacological innovation includes allosteric inhibitors and allosteric heterobifunctional degraders that can destroy targets. The design of chemical linkers in bifunctional degraders allows precise coordination between the target protein and the E3 ubiquitin ligase, enabling innovative drug discovery.

JOURNAL OF MOLECULAR BIOLOGY (2022)

Review Multidisciplinary Sciences

Neurodevelopmental disorders, immunity, and cancer are connected

Ruth Nussinov, Chung-Jung Tsai, Hyunbum Jang

Summary: Immunity plays a crucial role in both neurodevelopmental disorders and cancer, as the immune and nervous systems coevolve during embryonic development. Dysregulated signaling caused by germline or embryonic mutations can lead to changes in chromatin organization and gene accessibility, affecting the expression of essential genes in neurodevelopment. Similarly, dysregulated signaling resulting from somatic mutations contributes to cancer development. Both conditions involve small GTPases and their pathways, as well as dysregulation of TLRs, IL-1, GIT1, and FGFR signaling pathways. However, key differentiating factors are the timing and level of perturbation in specific cell types, indicating chromatin reorganization.

ISCIENCE (2022)

Article Biochemistry & Molecular Biology

Higher-order interactions of Bcr-Abl can broaden chronic myeloid leukemia (CML) drug repertoire

Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov

Summary: Bcr-Abl, a nonreceptor tyrosine kinase, plays a crucial role in leukemias, particularly chronic myeloid leukemia (CML). The fusion of Bcr and Abl leads to constitutive activation of Bcr-Abl. Oligomerization of Bcr-Abl is critical for its membrane clustering, MAPK signaling, and cell proliferation. Understanding the structural basis of Bcr-Abl oligomerization can guide the development of novel drugs targeting this process.

PROTEIN SCIENCE (2023)

Letter Oncology

Activation mechanisms of clinically distinct B-Raf V600E and V600K mutants

Mingzhen Zhang, Ryan Maloney, Yonglan Liu, Hyunbum Jang, Ruth Nussinov

CANCER COMMUNICATIONS (2023)

Review Pharmacology & Pharmacy

AlphaFold, allosteric, and orthosteric drug discovery: Ways forward

Ruth Nussinov, Mingzhen Zhang, Yonglan Liu, Hyunbum Jang

Summary: Drug discovery is a highly challenging and significant interdisciplinary aim. The success of AlphaFold, an AI-powered technology, has raised hopes for drug discovery, but its limitations need to be considered. Improving AlphaFold's performance in active state models can enhance the success rate of rational drug design.

DRUG DISCOVERY TODAY (2023)

Article Chemistry, Physical

Strategy toward Kinase-Selective Drug Discovery

Mingzhen Zhang, Yonglan Liu, Hyunbum Jang, Ruth Nussinov

Summary: Kinase drug selectivity is a challenge in cancer research. Researchers propose a protocol to identify unique geometric features in the drug pocket that can distinguish one kinase from others. They analyze the structural principles of kinase drug selectivity using experimental structures and artificial intelligence. The results show that there are binary units in the kinome that can distinguish kinases from each other.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2023)

Review Biophysics

Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK

Ruth Nussinov, Bengi Ruken Yavuz, M. Kaan Arici, Habibe Cansu Demirel, Mingzhen Zhang, Yonglan Liu, Chung-Jung Tsai, Hyunbum Jang, Nurcan Tuncbag

Summary: Neurodevelopmental disorders (NDDs) and cancer have similarities in terms of proteins, pathways, and mutations, but have different clinical symptoms. However, individuals with NDDs have a higher likelihood of developing cancer later on. This review explores how shared features can result in different medical conditions and why having an NDD first can increase the chances of malignancy.

BIOPHYSICAL REVIEWS (2023)

Article Genetics & Heredity

Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome

Bengi Ruken Yavuz, M. Kaan Arici, Habibe Cansu Demirel, Chung-Jung Tsai, Hyunbum Jang, Ruth Nussinov, Nurcan Tuncbag

Summary: Epidemiological studies show that individuals with neurodevelopmental disorders are more likely to develop certain types of cancer. While these disorders and cancer share proteins, pathways, and mutations, they differ in clinical outcomes. The key factor determining clinical outcome is signaling strength, with strong signaling promoting cell proliferation in cancer and moderate signaling affecting differentiation in neurodevelopmental disorders.

NPJ GENOMIC MEDICINE (2023)

Article Biochemistry & Molecular Biology

Cell phenotypes can be predicted from propensities of protein conformations

Ruth Nussinov, Yonglan Liu, Wengang Zhang, Hyunbum Jang

Summary: The propensities of protein conformations can predict cell function and suggest drug efficiency.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2023)

Review Biochemistry & Molecular Biology

Protein conformational ensembles in function: roles and mechanisms

Ruth Nussinov, Yonglan Liu, Wengang Zhang, Hyunbum Jang

Summary: The sequence-structure-function paradigm in molecular biology has been updated to include the concept of conformational ensembles, recognizing that proteins are dynamic and constantly transitioning between different conformational states. The number and stability of these states are crucial for protein function. Understanding conformational propensities is essential for studying diverse systems and can provide insights into the dynamics of protein ensembles in cells.

RSC CHEMICAL BIOLOGY (2023)

Article Genetics & Heredity

Predictive modeling of moonlighting DNA-binding proteins

Dana Mary Varghese, Ruth Nussinov, Shandar Ahmad

Summary: Moonlighting proteins are capable of performing multiple autonomous functions. In this study, human moonlighting DNA-binding proteins (mDBPs) were investigated and found to be distinguishable from other proteins with the same DNA-binding function. A machine learning model was developed to predict mDBPs from other DBPs with high accuracy.

NAR GENOMICS AND BIOINFORMATICS (2022)

暂无数据